TNDM
Earnings in 2 days · May 7, 2026 · After close
Signal
Mixed11
Price
1
Move+2.32%Positive session
Volume
1
Volume1.0× avgNormal activity
Technical
1
RSIRSI 50Momentum negative
PRICE
Prev Close
19.42
Open
19.59
Day Range19.15 – 20.43
19.15
20.43
52W Range9.98 – 29.65
9.98
29.65
50% of range
VOLUME & SIZE
Avg Volume
2.1M
FUNDAMENTALS
P/E Ratio
-6.5x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.62
High vol
Performance
1D
+2.32%
5D
+7.58%
1M
+3.65%
3M
+4.63%
6M
+30.64%
YTD
-9.60%
1Y
-6.67%
Best: 6M (+30.64%)Worst: YTD (-9.60%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
54% gross margin
Valuation
FAIR
P/E not available
Health
WEAK
CR 2.5 · FCF negative
Neutral
Key MetricsTTM
Market Cap$1.36B
Revenue TTM$1.01B
Net Income TTM-$204.71M
Free Cash Flow-$29.67M
Gross Margin53.8%
Net Margin-20.2%
Operating Margin-18.2%
Return on Equity-142.0%
Return on Assets-23.2%
Debt / Equity3.64
Current Ratio2.55
EPS TTM$-3.01

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong1 watch4 concern
20/100
Liquidity
2.55Strong
Leverage
3.64Concern
Coverage
-23.0xConcern
ROE
-142.0%Concern
ROIC
-27.8%Concern
Cash
$91MWatch
ANALYST COVERAGE37 analysts
BUY
+40.9%upside to target
L $21.00
Med $28.00consensus
H $56.00
Buy
2465%
Hold
1335%
24 Buy (65%)13 Hold (35%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
5/10
Technicals
RSI RangeRSI 50 — Bearish momentum
Volume
Volume FlowLean Distribution — selling pressure
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 2.55 — healthy liquidity
Upcoming Events
EEarnings ReportMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 107 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

PullbackGolden Cross · 50D leads 200D by 21.5%

-8.2% vs SMA 50 · +11.5% vs SMA 200

Momentum

RSI49.7
Neutral territory
MACD+0.40
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$29.65+49.2%
EMA 50
$22.12+11.3%
Current
$19.87
EMA 200
$19.06-4.1%
52W Low
$9.98-49.8%
52-Week RangeMid-range
$9.9850th %ile$29.65
Squeeze SetupVolume-based
No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow
Acc days:4
Dist days:9
Edge:+5 dist
Volume Context
Avg Vol (50D)1.6M
Recent Vol (5D)
1.6M+3%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 17 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$1.0B
$997.8M$1.0B
-$2.09
±1%
High17
FY2026(current)
$1.1B
$1.1B$1.1B
+7.6%-$0.76
±50%
High16
FY2027
$1.2B
$1.2B$1.3B
+12.1%$0.04
±50%
High17
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryTNDM
Last 8Q
+2.9%avg beat
Beat 4 of 8 quartersMissed 3 Estimates rising
+21%
Q2'24
+13%
Q3'24
+16%
Q4'24
-76%
Q1'25
-12%
Q2'25
-20%
Q3'25
Q4'25
+80%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
Neutral — mixed activity
90d20
Lake StreetHold → Buy
Feb 23
UPGRADE
Bank of America Sec…Neutral
Feb 20
UPGRADE
CitigroupNeutral
Aug 12
UPGRADE
Lake StreetBuy → Hold
Aug 11
DOWNGRADE
Piper SandlerOverweight → Neutral
Aug 7
DOWNGRADE
CitigroupNeutral → Buy
May 22
UPGRADE
Wells FargoEqual-Weight → Overweight
Apr 29
UPGRADE
Leerink PartnersOutperform
Apr 25
UPGRADE
Raymond JamesOutperform → Market Perform
Apr 24
DOWNGRADE
Wells FargoUnderweight → Equal-Weight
Nov 15
UPGRADE
Wells FargoOverweight → Underweight
Aug 9
DOWNGRADE
Wells FargoOverweight
Aug 9
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/2 SellsNet Selling
Novara Mark DavidEVP & CHIEF CO…
$4K
Mar 17
SELL
Novara Mark DavidEVP & CHIEF CO…
$46
Mar 5
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
abrdn plc
434K
2
Nuveen, LLC
364K
3
Assenagon Asset Management S.A.
179K
4
BANQUE PICTET & CIE SA
124K
5
Y-Intercept (Hong Kong) Ltd
78K
6
NEW YORK STATE TEACHERS RETIREMENT SYSTEM
66K
7
THRIVENT FINANCIAL FOR LUTHERANS
45K
8
OPPENHEIMER ASSET MANAGEMENT INC.
41K
News & Activity

TNDM News

20 articles · 4h ago

About

tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan

Industry
Surgical and Medical Instrument Manufacturing
CEO
John Sheridan
Leigh A. VossellerExecutive Vice President, Chief Financial Officer & Treasurer
Elizabeth Anne GasserExecutive Vice President and Chief Strategy & Product Officer
Susan MorrisonExecutive Vice President & Chief Administrative Officer
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
TNDM
$19.87+2.32%$1.4B+792.7%-2017.4%1500
$68.99+0.00%$13.4B1500
$91.17+0.00%$12.0B-4239.0%1500
$518.66+0.96%$11.9B-3008.0%1500
$223.70+8.31%$11.4B+6554.5%-2868.8%1500
$76.39+0.00%$10.7B52.9+2325815.3%-19.7%1500
$182.03+0.00%$10.6B1500
Sector avg+1.66%52.9+777720.8%-2430.6%1500